Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Rang in Aktien #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Aktienkurs
$8.92
Zuletzt synchronisiert: 2024-10-18
Marktkapitalisierung
$674.03M
Veränderung (1 Tag)
-5.14%
Veränderung (1 Jahr)
0.00%
Land
KR
Handel Jeisys Medical Inc. (287410)

Kategorie

EPS für Jeisys Medical Inc. (287410)
EPS zum June 2024 TTM: $0.26
Laut den aktuellen Finanzberichten und dem Aktienkurs von Jeisys Medical Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $0.26. Am Ende des Jahres 2022 betrug das EPS $0.30 eine Steigerung gegenüber dem EPS von 2021, das $0.16 betrug.
EPS-Verlauf von Jeisys Medical Inc. von 2020 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $0.26 5.04%
2023 $0.25 -16.06%
2022 $0.30 84.09%
2021 $0.16 64.49%
2020 $0.10 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$3.11 1,084.31%
US
$9.73 3,605.26%
US
$3.59 1,267.10%
IE
$2.48 844.40%
US
- -
DE